跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DURATOCIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DURATOCIN
Authorized
STANDARD
DURATOCIN
Ferring Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
32ab361ee8c11ecb
Company
Ferring Inc
Type
Standard
Approval Details
Approval Id
32ab361ee8c11ecb
Drug Approval Canada Name
DURATOCIN
Product Name
DURATOCIN
Status
Marketed
Status Date
2020-08-05
Original Market Date
2020-08-05
Din
02496526
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intramuscular , Intravenous
Schedule
Prescription
Ahfs
76:00.00
Atc Original
H01BB03 CARBETOCIN
Atc Name
h 01 bb 03
Aig Number
0132909001
Company Name
Ferring Inc
Company Address
500, 200 Yorkland Blvd, Toronto, Ontario, Canada, M2J 5C1
Active Ingredients
CARBETOCIN
100 MCG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
32ab361ee8c11ecb
Type
Standard
Back to Health Canada Approvals